Cargando…

STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes

BACKGROUND: Leukostasis is a key patho-physiological event responsible for capillary occlusion in diabetic retinopathy. Circulating monocytes are the main cell type entrapped in retinal vessels in diabetes. In this study, we investigated the role of the signal transducer and activator of transcripti...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mei, Obasanmi, Gideon, Armstrong, David, Lavery, Nuala-Jane, Kissenpfennig, Adrien, Lois, Noemi, Xu, Heping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615157/
https://www.ncbi.nlm.nih.gov/pubmed/31286987
http://dx.doi.org/10.1186/s12974-019-1533-1
_version_ 1783433310412734464
author Chen, Mei
Obasanmi, Gideon
Armstrong, David
Lavery, Nuala-Jane
Kissenpfennig, Adrien
Lois, Noemi
Xu, Heping
author_facet Chen, Mei
Obasanmi, Gideon
Armstrong, David
Lavery, Nuala-Jane
Kissenpfennig, Adrien
Lois, Noemi
Xu, Heping
author_sort Chen, Mei
collection PubMed
description BACKGROUND: Leukostasis is a key patho-physiological event responsible for capillary occlusion in diabetic retinopathy. Circulating monocytes are the main cell type entrapped in retinal vessels in diabetes. In this study, we investigated the role of the signal transducer and activator of transcription 3 (STAT3) pathway in diabetes-induced immune cell activation and its contribution to retinal microvascular degeneration. METHODS: Forty-one patients with type 1 diabetes (T1D) [mild non-proliferative diabetic retinopathy (mNPDR) (n = 13), active proliferative DR (aPDR) (n = 14), inactive PDR (iPDR) (n = 14)] and 13 age- and gender-matched healthy controls were recruited to the study. C57BL/6 J WT mice, SOCS3(fl/fl) and LysM(Cre/+)SOCS3(fl/fl) mice were rendered diabetic by Streptozotocin injection. The expression of the phosphorylated human and mouse STAT3 (pSTAT3), mouse LFA-1, CD62L, CD11b and MHC-II in circulating immune cells was evaluated by flow cytometry. The expression of suppressor of cytokine signalling 3 (SOCS3) was examined by real-time RT-PCR. Mouse plasma levels of cytokines were measured by Cytometric Beads Array assay. Retinal leukostasis was examined following FITC-Concanavalin A perfusion and acellular capillary was examined following Isolectin B4 and Collagen IV staining. RESULTS: Compared to healthy controls, the expression of pSTAT3 in circulating leukocytes was statistically significantly higher in mNPDR but not aPDR and was negatively correlated with diabetes duration. The expression of pSTAT3 and its inhibitor SOCS3 was also significantly increased in leukocytes from diabetic mice. Diabetic mice had higher plasma levels of IL6 and CCL2 compared with control mice. LysM(Cre/+)SOCS3(fl/fl) mice and SOCS3(fl/fl) mice developed comparative levels of diabetes, but leukocyte activation, retinal leukostasis and number of acellular capillaries were statistically significantly increased in LysM(Cre/+)SOCS3(fl/fl) diabetic mice. CONCLUSION: STAT3 activation in circulating immune cells appears to contribute to retinal microvascular degeneration and may be involved in DR initiation in T1D. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-019-1533-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6615157
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66151572019-07-18 STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes Chen, Mei Obasanmi, Gideon Armstrong, David Lavery, Nuala-Jane Kissenpfennig, Adrien Lois, Noemi Xu, Heping J Neuroinflammation Research BACKGROUND: Leukostasis is a key patho-physiological event responsible for capillary occlusion in diabetic retinopathy. Circulating monocytes are the main cell type entrapped in retinal vessels in diabetes. In this study, we investigated the role of the signal transducer and activator of transcription 3 (STAT3) pathway in diabetes-induced immune cell activation and its contribution to retinal microvascular degeneration. METHODS: Forty-one patients with type 1 diabetes (T1D) [mild non-proliferative diabetic retinopathy (mNPDR) (n = 13), active proliferative DR (aPDR) (n = 14), inactive PDR (iPDR) (n = 14)] and 13 age- and gender-matched healthy controls were recruited to the study. C57BL/6 J WT mice, SOCS3(fl/fl) and LysM(Cre/+)SOCS3(fl/fl) mice were rendered diabetic by Streptozotocin injection. The expression of the phosphorylated human and mouse STAT3 (pSTAT3), mouse LFA-1, CD62L, CD11b and MHC-II in circulating immune cells was evaluated by flow cytometry. The expression of suppressor of cytokine signalling 3 (SOCS3) was examined by real-time RT-PCR. Mouse plasma levels of cytokines were measured by Cytometric Beads Array assay. Retinal leukostasis was examined following FITC-Concanavalin A perfusion and acellular capillary was examined following Isolectin B4 and Collagen IV staining. RESULTS: Compared to healthy controls, the expression of pSTAT3 in circulating leukocytes was statistically significantly higher in mNPDR but not aPDR and was negatively correlated with diabetes duration. The expression of pSTAT3 and its inhibitor SOCS3 was also significantly increased in leukocytes from diabetic mice. Diabetic mice had higher plasma levels of IL6 and CCL2 compared with control mice. LysM(Cre/+)SOCS3(fl/fl) mice and SOCS3(fl/fl) mice developed comparative levels of diabetes, but leukocyte activation, retinal leukostasis and number of acellular capillaries were statistically significantly increased in LysM(Cre/+)SOCS3(fl/fl) diabetic mice. CONCLUSION: STAT3 activation in circulating immune cells appears to contribute to retinal microvascular degeneration and may be involved in DR initiation in T1D. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-019-1533-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-08 /pmc/articles/PMC6615157/ /pubmed/31286987 http://dx.doi.org/10.1186/s12974-019-1533-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Chen, Mei
Obasanmi, Gideon
Armstrong, David
Lavery, Nuala-Jane
Kissenpfennig, Adrien
Lois, Noemi
Xu, Heping
STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes
title STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes
title_full STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes
title_fullStr STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes
title_full_unstemmed STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes
title_short STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes
title_sort stat3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615157/
https://www.ncbi.nlm.nih.gov/pubmed/31286987
http://dx.doi.org/10.1186/s12974-019-1533-1
work_keys_str_mv AT chenmei stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes
AT obasanmigideon stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes
AT armstrongdavid stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes
AT laverynualajane stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes
AT kissenpfennigadrien stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes
AT loisnoemi stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes
AT xuheping stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes